Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer

PURPOSE: Despite decreased screening-based detection of clinically insignificant tumors, most diagnosed prostate cancers are still indolent, indicating a need for better strategies for detection of clinically significant disease before treatment. We hypothesized that patients with detectable circula...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennigan, S. Thomas, Trostel, Shana Y., Terrigino, Nicholas T., Voznesensky, Olga S., Schaefer, Rachel J., Whitlock, Nichelle C., Wilkinson, Scott, Carrabba, Nicole V., Atway, Rayann, Shema, Steven, Lake, Ross, Sweet, Amalia R., Einstein, David J., Karzai, Fatima, Gulley, James L., Chang, Peter, Bubley, Glenn J., Balk, Steven P., Ye, Huihui, Sowalsky, Adam G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746181/
https://www.ncbi.nlm.nih.gov/pubmed/31528835
http://dx.doi.org/10.1200/PO.19.00176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746181/
https://www.ncbi.nlm.nih.gov/pubmed/31528835
http://dx.doi.org/10.1200/PO.19.00176

Ejemplares similares